arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Celcuity Inc.

CELC
$80.00 ▼ -4.12 (-4.90%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
41 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Celcuity Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $4.4B
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 408.7% ↗
FCF / Share $-1.01 →
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Sep 23, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-52.84M
↓ -42.8% —
FCF / Share Free cash flow per share
$-1.01
— +0.4% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
3
Financial Health ↑
24
Cash Quality ↑
58

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 41 quarters